In blood samples from healthy donors and from patients with cancer, AC484 increased IFNγ-induced STAT1 phosphorylation and CXCL10 production, which suggested that AC484-enhanced pathway engagement resulted in amplified downstream functional effects (Extended Data Fig. 1s,t). This evidence concerns the gene IFNG and cancer.